Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2033331104', 'doi': 'https://doi.org/10.1016/j.diabres.2011.07.035', 'title': 'Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial', 'display_name': 'Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial', 'publication_year': 2011, 'publication_date': '2011-11-01', 'ids': {'openalex': 'https://openalex.org/W2033331104', 'doi': 'https://doi.org/10.1016/j.diabres.2011.07.035', 'mag': '2033331104', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21871686'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.diabres.2011.07.035', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S171311646', 'display_name': 'Diabetes Research and Clinical Practice', 'issn_l': '0168-8227', 'issn': ['0168-8227', '1872-8227'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5083581289', 'display_name': 'Wenying Yang', 'orcid': 'https://orcid.org/0000-0002-7997-9404'}, 'institutions': [{'id': 'https://openalex.org/I2801051648', 'display_name': 'China-Japan Friendship Hospital', 'ror': 'https://ror.org/037cjxp13', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801051648']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Wenying Yang', 'raw_affiliation_strings': ['Department of Endocrinology, China–Japan Friendship Hospital, Yinhua No. 2 East Road, Hepingli, Chao Yang District, Beijing 100029, China'], 'affiliations': [{'raw_affiliation_string': 'Department of Endocrinology, China–Japan Friendship Hospital, Yinhua No. 2 East Road, Hepingli, Chao Yang District, Beijing 100029, China', 'institution_ids': ['https://openalex.org/I2801051648']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049512929', 'display_name': 'Chang Yu Pan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210160531', 'display_name': "Chinese People's Liberation Army", 'ror': 'https://ror.org/05tf9r976', 'country_code': 'CN', 'type': 'government', 'lineage': ['https://openalex.org/I4210160531']}, {'id': 'https://openalex.org/I4210101382', 'display_name': "People's Liberation Army No. 150 Hospital", 'ror': 'https://ror.org/014nsap67', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210101382']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Chang Yu Pan', 'raw_affiliation_strings': ["Department of Endocrinology, General Hospital of Chinese People's Liberation Army, No. 28 Fu Xing Road, Beijing 100853, China"], 'affiliations': [{'raw_affiliation_string': "Department of Endocrinology, General Hospital of Chinese People's Liberation Army, No. 28 Fu Xing Road, Beijing 100853, China", 'institution_ids': ['https://openalex.org/I4210160531', 'https://openalex.org/I4210101382']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037882047', 'display_name': 'Conrad Tou', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Conrad Tou', 'raw_affiliation_strings': ['AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA.'], 'affiliations': [{'raw_affiliation_string': 'AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070167982', 'display_name': 'June Zhao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'June Zhao', 'raw_affiliation_strings': ['AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA.'], 'affiliations': [{'raw_affiliation_string': 'AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5007149007', 'display_name': 'Ingrid Gause‐Nilsson', 'orcid': 'https://orcid.org/0000-0002-3758-8237'}, 'institutions': [{'id': 'https://openalex.org/I4210143795', 'display_name': 'AstraZeneca (Sweden)', 'ror': 'https://ror.org/04wwrrg31', 'country_code': 'SE', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210143795']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Ingrid Gause-Nilsson', 'raw_affiliation_strings': ['AstraZeneca Research & Development, Mölndal S-431 83, Sweden'], 'affiliations': [{'raw_affiliation_string': 'AstraZeneca Research & Development, Mölndal S-431 83, Sweden', 'institution_ids': ['https://openalex.org/I4210143795']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3970, 'currency': 'USD', 'value_usd': 3970, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 7.902, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 92, 'citation_normalized_percentile': {'value': 0.946398, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '94', 'issue': '2', 'first_page': '217', 'last_page': '224'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Role of AMP-Activated Protein Kinase in Cellular Metabolism', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10560', 'display_name': 'Management of Diabetes Mellitus and Hypoglycemia', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/saxagliptin', 'display_name': 'Saxagliptin', 'score': 0.9777653}, {'id': 'https://openalex.org/keywords/continuous-glucose-monitoring', 'display_name': 'Continuous Glucose Monitoring', 'score': 0.552494}, {'id': 'https://openalex.org/keywords/diabetes', 'display_name': 'Diabetes', 'score': 0.523377}, {'id': 'https://openalex.org/keywords/metformin', 'display_name': 'Metformin', 'score': 0.517565}, {'id': 'https://openalex.org/keywords/type-2-diabetes', 'display_name': 'Type 2 Diabetes', 'score': 0.512809}, {'id': 'https://openalex.org/keywords/insulin-signaling', 'display_name': 'Insulin Signaling', 'score': 0.506545}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitor', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'score': 0.4476921}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.4382517}], 'concepts': [{'id': 'https://openalex.org/C2780323712', 'wikidata': 'https://www.wikidata.org/wiki/Q19484', 'display_name': 'Metformin', 'level': 3, 'score': 0.9796458}, {'id': 'https://openalex.org/C2780282729', 'wikidata': 'https://www.wikidata.org/wiki/Q3121121', 'display_name': 'Saxagliptin', 'level': 5, 'score': 0.9777653}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.91264707}, {'id': 'https://openalex.org/C2780473172', 'wikidata': 'https://www.wikidata.org/wiki/Q5572518', 'display_name': 'Glycemic', 'level': 3, 'score': 0.80917484}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6846864}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.65178525}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.6057453}, {'id': 'https://openalex.org/C2778199505', 'wikidata': 'https://www.wikidata.org/wiki/Q2992990', 'display_name': 'Postprandial', 'level': 3, 'score': 0.5774369}, {'id': 'https://openalex.org/C2780668416', 'wikidata': 'https://www.wikidata.org/wiki/Q202758', 'display_name': 'Hypoglycemia', 'level': 3, 'score': 0.57559407}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.5744694}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.44805527}, {'id': 'https://openalex.org/C2778763485', 'wikidata': 'https://www.wikidata.org/wiki/Q419770', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'level': 4, 'score': 0.4476921}, {'id': 'https://openalex.org/C2910068830', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 Diabetes Mellitus', 'level': 3, 'score': 0.4419028}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.4382517}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.41918445}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34889576}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.33782172}, {'id': 'https://openalex.org/C2779284873', 'wikidata': 'https://www.wikidata.org/wiki/Q419832', 'display_name': 'Sitagliptin', 'level': 4, 'score': 0.12610477}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D044466', 'descriptor_name': 'Asians', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D004151', 'descriptor_name': 'Dipeptides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000704', 'descriptor_name': 'Analysis of Variance', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001208', 'descriptor_name': 'Asia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001208', 'descriptor_name': 'Asia', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D044466', 'descriptor_name': 'Asians', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': False}, {'descriptor_ui': 'D015415', 'descriptor_name': 'Biomarkers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015415', 'descriptor_name': 'Biomarkers', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004151', 'descriptor_name': 'Dipeptides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D004151', 'descriptor_name': 'Dipeptides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006442', 'descriptor_name': 'Glycated Hemoglobin A', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D006442', 'descriptor_name': 'Glycated Hemoglobin A', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008687', 'descriptor_name': 'Metformin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.diabres.2011.07.035', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S171311646', 'display_name': 'Diabetes Research and Clinical Practice', 'issn_l': '0168-8227', 'issn': ['0168-8227', '1872-8227'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21871686', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.8}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 24, 'referenced_works': ['https://openalex.org/W1532170875', 'https://openalex.org/W1969932276', 'https://openalex.org/W1970125713', 'https://openalex.org/W1977619586', 'https://openalex.org/W1991565451', 'https://openalex.org/W2012437459', 'https://openalex.org/W2015790940', 'https://openalex.org/W2053369310', 'https://openalex.org/W2056526409', 'https://openalex.org/W2070657377', 'https://openalex.org/W2103058881', 'https://openalex.org/W2108646121', 'https://openalex.org/W2108771199', 'https://openalex.org/W2109728760', 'https://openalex.org/W2113936882', 'https://openalex.org/W2114927834', 'https://openalex.org/W2123355624', 'https://openalex.org/W2124620553', 'https://openalex.org/W2126065052', 'https://openalex.org/W2159205789', 'https://openalex.org/W2171512247', 'https://openalex.org/W2275139239', 'https://openalex.org/W2337454357', 'https://openalex.org/W2418682171'], 'related_works': ['https://openalex.org/W2949067235', 'https://openalex.org/W2189353858', 'https://openalex.org/W2107058745', 'https://openalex.org/W2103058881', 'https://openalex.org/W2094649585', 'https://openalex.org/W2088180663', 'https://openalex.org/W2073314743', 'https://openalex.org/W2055851987', 'https://openalex.org/W2033331104', 'https://openalex.org/W141423443'], 'abstract_inverted_index': {'Aim': [0], 'To': [1], 'assess': [2], 'efficacy': [3], 'and': [4, 24, 101, 179, 195, 197], 'safety': [5], 'of': [6, 140, 165], 'saxagliptin': [7, 44, 150], 'added': [8, 172], 'to': [9, 43, 69, 110, 173], 'metformin': [10, 14, 29, 37, 49, 56, 75, 84, 152, 157, 174, 194], 'versus': [11, 81, 91, 98, 116, 133, 154], 'placebo': [12, 54, 82, 155], 'plus': [13, 48, 55, 74, 83, 151, 156], 'in': [15, 88, 163, 167, 183], 'Asian': [16, 184], 'patients': [17, 123, 141, 166, 185], 'with': [18, 186, 193], 'type': [19], '2': [20], 'diabetes': [21], 'mellitus': [22], '(T2DM)': [23], 'inadequate': [25, 190], 'glycemic': [26, 127, 177, 191], 'control': [27, 178, 192], 'on': [28, 35], 'alone.': [30], 'Methods': [31], 'Adults': [32], '(HbA1c': [33, 129], '7.0–10.0%,': [34], 'stable': [36], '≥1500': [38], 'mg/day)': [39], 'were': [40, 161], 'randomized': [41], '1:1': [42], '5': [45], 'mg': [46], 'daily': [47], '(n': [50, 57], '=': [51, 58, 136], '283)': [52], 'or': [53], '287).': [59], 'The': [60, 138], 'primary': [61], 'end': [62], 'point': [63], 'was': [64, 147, 180], 'HbA1c': [65, 89], 'change': [66], 'from': [67, 108], 'baseline': [68], 'Week': [70], '24.': [71], 'Results': [72], 'Saxagliptin': [73, 171], 'provided': [76], 'significant': [77], 'adjusted': [78], 'mean': [79], 'decreases': [80], '(p': [85], '≤': [86], '0.0052)': [87], '(−0.78%': [90], '−0.37%),': [92], 'fasting': [93], 'plasma': [94], 'glucose': [95, 103], '(−1.14': [96], 'mmol/L': [97], '−0.58': [99], 'mmol/L),': [100], 'postprandial': [102], 'area': [104], 'under': [105], 'the': [106], 'curve': [107], '0': [109], '180': [111], 'min': [112], '(−315': [113], 'mmol': [114, 118], 'min/L': [115], '−160': [117], 'min/L).': [119], 'Significantly': [120], 'more': [121], 'saxagliptin-treated': [122], 'achieved': [124], 'a': [125], 'therapeutic': [126], 'response': [128], '<': [130], '7.0%)': [131], '(46.5%': [132], '30.5%;': [134], 'p': [135], '0.0001).': [137], 'proportion': [139], 'experiencing': [142], 'adverse': [143], 'events': [144, 160], '(excluding': [145], 'hypoglycemia)': [146], 'similar': [148], 'for': [149], '(42.8%)': [153], '(40.8%).': [158], 'Hypoglycemic': [159], 'reported': [162], '1.4%': [164], 'each': [168], 'group.': [169], 'Conclusion': [170], 'significantly': [175], 'improved': [176], 'well': [181], 'tolerated': [182], 'T2DM': [187], 'who': [188], 'had': [189], 'diet': [196], 'lifestyle': [198], 'modification.': [199]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2033331104', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 4}, {'year': 2018, 'cited_by_count': 6}, {'year': 2017, 'cited_by_count': 12}, {'year': 2016, 'cited_by_count': 14}, {'year': 2015, 'cited_by_count': 13}, {'year': 2014, 'cited_by_count': 21}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 7}], 'updated_date': '2024-09-14T21:18:28.274380', 'created_date': '2016-06-24'}